| Papers [1-15] of 77 :: [Page 1 of 6] | | Go to page : 1 2 3 4 5 6 —> | Search results on "HPV VACCINATION": |
|
|
HPV Vaccination, 2007.
A discussion of mandating the quadrivalent human papilloma virus vaccination in Californina specifically for girls.
1,643 words (approx. 6.6 pages), 7 sources, APA, $ 53.95
»
Click here to show/hide summary
Abstract
This study considers the issue of preventing the quadrivalent human papilloma virus (HPV) through a immunization program of girls in a California school. The population of the study is specifically Latino, and issues surrounding health care in the Latino community are discussed. The efficacy of the vaccination is described as are the methods in which this disease is transferred. The paper also explains the dangers of HPV, giving statistics of the consequences of infection. Methods of prevention, including vaccination, are also highlighted. The paper concludes that further research which include studies to determine the long term efficacy of the vaccination as well as the length of protection it offers is necessary.
Outline
Abstract
Background/Review of Literature
Discussion/Recommendations for Further Study
From the Paper
"According to the Centers for Disease Control, Advisory Committee on Immunization and Practices, Resolution 6/06-2 the administration of the quadrivalent Human Papilloma Virus vaccination is suggested for administration to girls as young as 9 but preferably in the age set of 11-12, and as a catch up vaccination for girls aged 13-18. The vaccination is to be given in three staggered doses with the second dose given 2 months from the first and the third 6 months after the first dose. This is based on the positive research findings of both non-profit research groups and pharmaceutical companies developing preventative HPV vaccinations. This work addresses the validity of mandating this vaccine in Solano County California, upon these age guidelines as a prophylactic measure to decrease the incidence of the specific HPV types (6,11,16,18) associated with the vaccination, namely the Merck vaccination trade name Gardasil. In addition to this informative resolution the California Department of Health Services has obtained the vaccination and has made compatible resolutions to vaccinate girls according to the national recommendations, either through private physicians or through state and local agency immunization programs, (California Vaccines for Children (VFC) Program Providers) such as those found in Solano County."
| |
|
HIV Vaccines, 2006.
This paper discusses the history of the development of a vaccine for HIV.
1,270 words (approx. 5.1 pages), 5 sources, MLA, $ 43.95
»
Click here to show/hide summary
Abstract
This paper explains that, since Professor Robert Gallo confirmed etiological agents of AIDS in 1984, scientists in the United States, along with many other countries, have been making tremendous strides in the race to develop a vaccine for HIV. The author points out that the problem researchers have been facing is that the HIV virus does not respond to classical vaccination approaches, which have been used for other vaccines including smallpox and polio. The paper relates that, once the vaccine has been developed and released to the general population for use, scientists may see a decrease in illness even though not all persons have been given the vaccination.
From the Paper
"The two vaccine mechanisms differ in how the genes are packaged, with one being a naked version (can't reconstitute into a contagious virus) and the other a weakened type. Since only HIV gene fragments are attached to the adenovirus, ones that cannot replicate, any participants in the study would not have reason to believe that they can become infected with the HIV virus. Directors of this study feel that using the adenovirus vector appears to be the most promising advance in the past years attempts of research. Half of the participants will be from the Americas, while the other half will be in Southern Africa. The participants will be divided into two groups and will get four injections that will be spread out over a six month period. Half will be given the vaccine while the other half will get the placebo."
| |
|
Vaccines, 2005.
A description with examples of modern developments in vaccines.
2,628 words (approx. 10.5 pages), 13 sources, MLA, $ 79.95
»
Click here to show/hide summary
Abstract
The paper describes through examples, the principles that underpin modern developments in vaccination strategies. It gives a background to the development of vaccines, and describes how they work and the bodies immune response. It also looks at current developments in vaccinations and gives detailed descriptions of various vaccination methods. It uses specific U.K.examples with the MMR vaccine.
From the Paper
"The response to immunisation/vaccination can be enhanced by a number of agents, and collectively these are termed adjuvants. These are a heterogeneous group of compounds, with several different mechanisms of action. In the history of immunisation/vaccination, many compounds have been used empirically, with little knowledge about how they may work. Several vaccines are composed of proteins that have bee precipitated with alum, and others are emulsified in oil based compounds. One of the best known emulsifying agent's is Freund's complete adjuvant, which contains mycobacterial derivatives. Amongst these, bacterial cell wall components such as lipopolysaccharide are powerful immune stimulants, having an activating effect on macrophages and T-cells."
| |
|
Elderly Access to Vaccinations, 2005.
Argues that America must ensure that programs to provide pneumococcal and influenza vaccination to the elderly are implemented to assure long-term health for senior citizens and the American health care system.
6,315 words (approx. 25.3 pages), 18 sources, MLA, $ 147.95
»
Click here to show/hide summary
Abstract
This paper determines that, because of scientific and medical data available, it is imperative for elder citizens to have access to pneumococcal and influenza immunizations. Through a thorough study of various factors, the paper concludes that failing to make these immunizations available, will result in widespread sickness and affliction, and a rising burden on America's health care tab.
Introduction
Data
What is Being Done
Effects of Failing to Provide Pneumococcal and Influenza Vaccinations for Senior Citizens
Conclusion
From the Paper
"The overwhelming conclusion of this paper is that available funds should immediately be spent to encourage our nation's senior citizens not only to get a influenza vaccination, but a pneumococcal vaccination as well.
The flu-shot shortage makes it more even more imperative for senior citizens to get a second, often overlooked vaccine that protects against a type of pneumonia germ that's a common complication of influenza.
The pneumococcal vaccine is a one-time shot for anyone 65 or older. Younger people with heart and lung illnesses, diabetes or weak immune systems need it as well, but the greatest urgency is to get the vaccination affordable and available to our nation's elderly.. It's not a replacement for a flu shot; high-risk patients should continue trying to find that.
But many of the same people most vulnerable to flu - namely, our nation's elderly -- also are at high risk from this dangerous bacterial infection. They need the pneumococcal vaccine anyway - so the focus should be on making the influenza vaccination available right alongside the pneumococcal vaccination."
| |
|
Vaccinations, 2003.
Discusses mass vaccinations as a public health achievement.
2,025 words (approx. 8.1 pages), 11 sources, $ 71.95
»
Click here to show/hide summary
Abstract
The paper looks at the controversy surrounding mandatory vaccination programs for infants and children. It looks at health concerns and risks and provides an overview of vaccinations, including evidence supporting the vaccination program.
From the Paper
"Introduction
Mass vaccination has been characterized as the greatest public health triumph of the century, having saved millions of lives and prevented the crippling of countless others (Going with the herd..., 1998, p. 13). Throughout the Western world,..."
|
| Term Paper # 4872 |
temporarily unavailable
|
|
| Term Paper # 71364 |
temporarily unavailable
|
|
|
|
The Search for an HIV Vaccine, 2002.
An examination of the medical research being performed in the search for a vaccine against HIV and AIDS.
2,028 words (approx. 8.1 pages), 9 sources, APA, $ 64.95
»
Click here to show/hide summary
Abstract
The paper describes how the HIV vaccine attacks the immune system with the T-Cells. Also, it discusses different types of vaccines and how they work along with leading causes of AIDS and how it has become an epidemic. It examines different forms of research and other attempts at creating a vaccine in the past.
From the Paper
"Since the HIV epidemic began in the 1970?s, it is estimated that 22 million persons are infected with the virus that causes AIDS. There are 3 million new infections each year with 65 percent of these cases in developing countries. There is no cure for AIDS and the outlook for finding a cure is very bleak, therefore a preventive vaccine is urgently needed to control the spread of HIV/AIDS. It is important to remember that being HIV positive does not equate to having AIDS, however it is only a matter of time that the virus will progress to the disease."
| |
|
The Promise of DNA Vaccines, 2006.
A review of recent work on DNA vaccines.
1,076 words (approx. 4.3 pages), 8 sources, MLA, $ 37.95
»
Click here to show/hide summary
Abstract
The paper examines recent developments in the field of DNA vaccines. It discusses progress in vaccines against rabies, cancer and HIV / AIDS, as well as the role of the United Nations' Joint Program on HIV/AIDS (UNAIDS) in current medical studies.
From the Paper
"Areas where the development of the DNA vaccine is concentrated are rabies, cancer and HIV. A DNA vaccine has been developed that protects monkeys from becoming infected with rabies. "DNA encodes for the surface glycoprotein of the rabies virus that induces high level of neutralizing antibodies." This is promising, since the DNA vaccine is less expensive, easy to use, and does not require refrigeration. As a result, the vaccine could be supplied worldwide, especially in areas where rabies is an epidemic."
| |
|
Vaccine Technology, 2004.
A brief discussion of the importance of modern-day vaccines in preventing epidemics.
1,025 words (approx. 4.1 pages), 3 sources, MLA, $ 36.95
»
Click here to show/hide summary
Abstract
This paper explains how one of the most important health advances of the 20th century has been immunization. It looks at how this development has stopped the spread of several potentially fatal diseases and explains that DNA vaccines have become the most promising area of vaccinology. The paper briefly looks at the technology of DNA vaccines and how these could be used in the future.
From the Paper
"DNA vaccines have the potential to be used as therapy, designed to treat a particular active disease, such as inducing cell-medicated immunity to bowel, or breast cells that express cancer antigens, thus causing the body to identify and kill tumor cells (Simmerman pg). In fact, researchers are now studying DNA vaccines for cervical cancer (Simmerman pg). For over a decade, investigators have been extensively using animal models to research DNA vaccines and recent trials have used small numbers of humans to determine treatment tolerance and immune response (Simmerman pg). Since the majority of these trials are phase I, they focus on safety and do not measure efficacy, however, in trials for hepatitis B, herpes, HIV, malaria, adenocarcinoma of the breast and colon, and lymphoma, the subjects have tolerated the vaccines relatively well (Simmerman pg)."
| |
|
Minorities and HIV Vaccine Trials, 2004.
Discusses why minorities are unwilling participants in HIV vaccine trials.
1,000 words (approx. 4.0 pages), 3 sources, MLA, $ 35.95
»
Click here to show/hide summary
Abstract
In recent years, HIV has begun to move away from being an automatic death sentence and toward the status of being a chronic, but manageable illness. This paper presents an examination of HIV vaccine clinical trials and examines whether or not minorities are comfortable participating in them. The writer examines the historic Tuskegee syphilis trial and applies some of the problems there to the current hesitancy by minorities to participate in HIV vaccines clinical trials. The paper is based on a literature review.
From the Paper
"The medical community has a documented lack of minority volunteers willing to participate in clinical trials for HIV medications and other treatments. There are several factors that contribute to this trend including a basic mistrust that the minority will be given a fair amount of the treatment in question, as well as historic problems with medical trials and minorities in the past.
(Timeline http://www.cdc.gov/nchstp/od/tuskegee/time.htm)
The need to recruit minority participants for clinical trials is obvious. Minority people get ill and they get disorders. They are part of the population that the medical community is attempting to assist and their participation in clinical trials can help that process move more quickly and efficiently."
| |
|
Anthrax Vaccine Immunization, 2002.
A look at the ethics of the anthrax vaccine immunization.
1,400 words (approx. 5.6 pages), 10 sources, $ 53.95
»
Click here to show/hide summary
Abstract
This paper looks at the idea of the Anthrax immunisation problem and the philosophies of Kant and Mills along with a Utilitarian approach as to whether it is bets to inoculate or not. The paper discusses Kant along side Mills and concludes that in personal views Mills would be the best approach to take.
| |
|
HPV: The Overlooked Virus, 2001.
This paper discusses an often-overlooked sexually transmitted virus: HPV.
2,400 words (approx. 9.6 pages), 7 sources, $ 73.95
»
Click here to show/hide summary
Abstract
The author writes from a personal perspective, citing real-life friends suffering from this virus. Discussion includes the topic of related cancers that may arise as a result of contraction of this virus.
From the Paper
"Human Papillomavirus (HPV) is the most common sexually transmitted disease (STD) in the United States, yet it remains one of the least discussed. Junior and Senior High Schools barely, if at all, discuss HPV in sex education classes. The average parent does not understand HPV, therefore the knowledge is not relayed to the child. By the time physicians are consulted, it is often too late. Education on the wide spread and rapidly growing virus has much to offer safe sex and sex prevention campaigns. One possibility as to why HPV education has been neglected could be related to the fact that available information is often contradictory, outside of HPV having the ability to be a silent infection."
| |
|
The Vaccines for Children Program, 2002.
A look at the politics of this immunization program.
2,400 words (approx. 9.6 pages), 6 sources, $ 89.95
»
Click here to show/hide summary
Abstract
This ten-page graduate level paper describes the Vaccines for Children (VFC) Program, its inception and policy descriptions as directed by former president Bill Clinton and Senator Hillary Clinton.
| |
|
Vaccinations in the U.S., 2002.
Trends in U.S. immunizations.
3,150 words (approx. 12.6 pages), 12 sources, $ 115.95
»
Click here to show/hide summary
Abstract
This paper examines and analyzes immunization trends in the United States, discusses shifts in immunizations and why they occurred, and notes the key problems of vaccines.
|
|
|
